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a b s t r a c t
Pancreatic exocrine and endocrine lineages arise from multipotent pancreatic progenitor cells (MPCs).
Exploiting the mechanisms that govern expansion and differentiation of these cells could enhance efforts to
generate β-cells from stem cells. Although our prior work indicates that the canonical Wnt signaling
component β-catenin is required qualitatively for exocrine acinar but not endocrine development, precisely
how this requirement plays out at the level of MPCs and their lineage-restricted progeny is unknown. In
addition, the contribution of β-catenin function to β-cell development remains controversial. To resolve the
potential roles of β-catenin in development of MPCs and β-cells, we generated pancreas- and pre-endocrine-
speciﬁc β-catenin knockout mice. Pancreas-speciﬁc loss of β-catenin produced not only a dramatic reduction
in acinar cell numbers, but also a signiﬁcant reduction in β-cell mass. The loss of β-cells is due not to a defect
in the differentiation of endocrine precursors, but instead correlates with an early and speciﬁc loss of MPCs.
In turn, this reﬂects a novel role for β-catenin in maintaining proximal–distal patterning of the early
epithelium, such that distal MPCs resort to a proximal, endocrine-competent “trunk” fate when β-catenin is
deleted. Moreover, β-catenin maintains proximal–distal patterning, in part, by inhibiting Notch signaling.
Subsequently, β-catenin is required for proliferation of both distal and proximal cells, driving overall organ
growth. In distinguishing two distinct roles for β-catenin along the route of β-cell development, we suggest
that temporally appropriate positive and negative manipulation of this molecule could enhance expansion
and differentiation of stem cell-derived MPCs.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The adult pancreas can be divided into two functionally distinct
domains, the exocrine function constituted by enzyme-secreting
acinar cells and ducts, and the endocrine function performed by
the islets of Langerhans. The division between the two domains
begins shortly after speciﬁcation where the pancreatic epithelium is
separated into a distal “tip” domain at the periphery of the organ,
which contains multipotent pancreatic progenitors (MPCs), and a
proximal trunk domain, which contains bipotent progenitors that
give rise to islet and duct cells. The capability of MPCs to produce all
pancreatic lineages lasts roughly until the secondary transition at
E13.5, after which distal tips are restricted to an acinar fate (Pan and
Wright, 2011; Zhou et al., 2007). The early speciﬁcation, maintenance
and self-renewal of embryonic progenitors is critical to the develop-
ment of the adult organ, as evidenced by the generation of a
dysfunctional and smaller pancreas when early progenitors are
partially ablated (Stanger et al., 2007).
With an ultimate goal of generating β-cells from stem cells, much
effort has gone into understanding the transcription factors and
intercellular signals that control pancreas progenitor patterning,
expansion and differentiation (Pan and Wright, 2011). As signal
transduction pathways mediate the response of progenitors to their
microenvironment, they might serve as facile targets for manipulating
stem cell differentiation. Nonetheless, while metazoan development
requires only a few core signaling pathways, these can be deployed in
complex and changing ways during organogenesis. This is exempliﬁed,
in the pancreas, by recent studies of the Notch signaling pathway.
Originally implicated speciﬁcally as a negative regulator of endocrine
differentiation (Apelqvist et al., 1999; Jensen et al., 2000), Notch has
since been shown to inhibit acinar development as well (Esni et al.,
2004; Hald et al., 2003; Murtaugh et al., 2003), potentially through
modulating proximal–distal patterning of the early organ (Afelik et al.,
2012; Magenheim et al., 2011; Schaffer et al., 2010). Although much
has been gleaned from studying Notch and other pathways individu-
ally, relatively little is known about these signals coalesce to pattern
and specify progenitors in the developing pancreas.
The goal of the present study is to elucidate the cellular
mechanisms by which β-catenin, a component of the Wnt signal-
ing pathway, controls the allocation of endocrine and exocrine
lineages from pancreatic progenitor cells. In previous studies using
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two different “Pdx1-Creearly” transgenic mice, both driving recom-
bination in the early embryonic pancreas, conditional
β-catenin knockout pancreata were found to be drastically smaller
than wild-type and largely devoid of exocrine acinar cells, while
containing a qualitatively normal complement of endocrine α- and
β-cells (Murtaugh et al., 2005; Wells et al., 2007). However,
deleting β-catenin using a different “Pdx1-Crelate” transgene,
beginning several days later in development (Heiser et al., 2006),
produced little effect on acinar cell development but caused a mild
decrease in islet cell mass (Dessimoz et al., 2005). It was hypothe-
sized in that study that β-catenin was required separately for
proliferation or survival of endocrine cells and exocrine progeni-
tors. The discordant results of these studies may reﬂect the
efﬁciency and timing of the different Pdx1-Cre deletor strains used
(Murtaugh, 2008).The requirement for β-catenin in acinar cells
persists through adulthood, when it is necessary for steady-state
turnover and acinar cell regeneration following injury (Keefe et al.,
2012). The role of Wnt/β-catenin signaling in differentiated endo-
crine cells has been an area of debate, with some studies suggest-
ing it promotes β-cell proliferation and function (Dabernat et al.,
2009; Rulifson et al., 2007), and another indicating that it is
dispensable for adult mouse β-cell proliferation (Keefe et al.,
2012). Together, these studies suggest that the contribution of β-
catenin to endocrine islet development remains to be unraveled.
Using time- and lineage-speciﬁc deletion experiments, we sought
to investigate the roles of β-catenin during embryonic pancreas
development, particularly in establishing endocrine β-cell mass.
Materials and methods
Mice
All experiments were performed according to protocols
approved by the University of Utah IACUC. We obtained several
mouse strains from the Jackson Laboratory: ﬂoxed and germline β-
catenin loss-of-function mice (Ctnnb1tm2Kem/J and Ctnnb1tm2.1Kem,
henceforth Ctnnb1lox and Ctnnb1Δ, respectively) (Brault et al.,
2001); Ngn3-Cre BAC transgenic mice (Schonhoff et al., 2004)
and the Cre-dependent EYFP reporter strain Gt(ROSA)26Sortm1(EYFP)
Cos (Srinivas et al., 2001), henceforth R26REYFP. Pdx1-Cre and Pdx1-
CreERT transgenic mice (Gu et al., 2002) were provided by Doug
Melton (Harvard University). To induce recombination with the
Pdx1-CreERT transgene, we administered tamoxifen (Sigma) sus-
pended in corn oil (Sigma) to pregnant dams, typically 8–16 weeks
of age, by oral gavage. Embryos were genotyped by PCR, using
primer sets described previously (Gu et al., 2002; Murtaugh et al.,
2005).
Tissue processing and staining
Pregnant dams were euthanized with isoﬂurane followed by
cervical dislocation. Whole embryos (E13.5 and younger) and
pancreata (E14.5 and later) were dissected in ice-cold PBS for
processing. Tissues were ﬁxed overnight at room-temperature
with zinc-buffered formalin (Polysciences) for parafﬁn sections
or with 4% paraformaldehyde/PBS (2 h-overnight at 4 1C for frozen
sections, and further processed as previously (Keefe et al., 2012;
Kopinke and Murtaugh, 2010; Murtaugh et al., 2005)). A series of
duplicate parafﬁn sections (6 mm) were collected sequentially
across multiple slides, spaced with skipping to span the entire
pancreas in the following age-dependent manner: for E17.5, 10
slides with 180 mm between sections; E12.5–E14.5, 8 slides with
96 mm between sections; E11.5, 7 slides with 84 mm between
sections on slides. In this way, the entire volume of each pancreas
is sample on multiple individual slides. Similarly, frozen sections
(8 mm) were collected serially over 6–10 slides such that the each
slide contained representative sections throughout the organ. For
labeling S-phase nuclei, mice were injected with BrdU (50 mg/g
body weight) one hour prior to sacriﬁce.
Antibodies used for immunostaining are listed in Table S1, and
all secondary antibodies (raised in donkey) were purchased from
Jackson Immunoresearch. Immunostaining was performed as pre-
viously (Keefe et al., 2012; Kopinke and Murtaugh, 2010;
Murtaugh et al., 2005), including high-temperature antigen retrie-
val for parafﬁn sections. For anti-BrdU staining, frozen sections
were pre-treated with DNase I (700 u/ml, in 40 mM Tris–HCl pH
7.4, 10 mM NaCl, 6 mM MgCl2, and 10 mM CaCl2) at room tem-
perature for 30 min (Ye et al., 2007). Bright ﬁeld images were
obtained using an Olympus CX41 microscope and MicroSuite
software. For immunoﬂuorescence, Fluoromount-G (Southern Bio-
tech) was used as a mounting substrate and images were obtained
using an Olympus IX71 microscope and MicroSuite software.
Identical exposure times and post-processing adjustments per-
formed in Adobe Photoshop were used across control and experi-
mental genotypes.
Quantiﬁcation and analysis
To measure β-cell mass, pancreas size, and volume or number
of cells expressing various markers, serial sections were stained by
immunohistochemistry, and all sections on a single slide were
photographed individually (4 original magniﬁcation at E17.5,
and 10–20 for all other time points), to provide a representation
of the entire pancreas. ImageJ (NIH) software was used to measure
the surface area occupied by stained tissue. For Ptf1a, c-Myc, and
Ngn3 at E11.5 and E12.5, stained nuclei were counted in Adobe
Photoshop. The total number of cells per pancreas (E11.5–E13.5)
was estimated by multiplying the number of cells counted per
slide by the number of slides in the series. Calculations, graphs and
P-values (two-tailed, unpaired t-test) were generated in Microsoft
Excel, and results are presented as mean7s.e.m.
For lineage tracing experiments using Pdx1-CreERT and
R26REYFP, we photographed several independent ﬁelds (20
original magniﬁcation), per embryo, across multiple pancreatic
sections per slide. For acinar cell labeling indices, we used the
additive image overlay feature of ImageJ (NIH) software to identify
the overlap of DAPI, amylase (acinar cells) and EYFP, and counted
cells using the Analyze Particles function (Kopinke and Murtaugh,
2010). For all other differentiation markers, cells were counted
using the Count Tool in Adobe Photoshop.
Explant cultures and wholemount immunostaining
For ex vivo explant cultures, the dorsal buds of E11.5 pancreata
were dissected in ice-cold sterile PBS, and cultured at the air-
media interface on 0.4 mm pore size PTFE cell culture inserts
(Millipore), in DMEM with 10% fetal bovine serum and antibiotics.
A small piece of tissue was collected for genotyping purposes at
the time of dissection. Explants were treated with 100 nM of the
γ-secretase inhibitor DBZ (Millipore 565789) for 3 days, while
controls received no treatment. Media was changed daily.
Wholemount immunoﬂuorescence was performed as pre-
viously described (Kopinke and Murtaugh, 2010). Brieﬂy, explants
were ﬁxed overnight in 4% PFA, washed and stored in methanol
until staining. For staining, explants were rehydrated to PBS,
permeabilized for 1 h with 1% Triton-X100 in PBS, and then placed
in blocking solution (5% donkey serum and 0.3% Triton X-100) for
2 h. Primary and secondary antibody incubations were performed
overnight at room temperature. Explants were cleared in BABB
(2:1 benzyl alcohol:benzyl benzoate) prior to imaging. Confocal
images were obtained using an Olympus FV-1000 microscope.
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Results
Both pancreas size and beta-cell mass depend on β-catenin function
in multipotent progenitor cells
As in our previous study (Murtaugh et al., 2005), we used the
Pdx1-Cre early transgene (henceforth, Pdx1-Cre) (Gu et al., 2002;
Heiser et al., 2006) to delete the conditional Ctnnb1lox allele (Brault
et al., 2001), producing pancreas-speciﬁc β-catenin knockout
(PBKO) mice (Fig. 1A). Conﬁrming published results, we found
that mutant pancreata were drastically smaller at late fetal stages,
due mostly to the loss of exocrine acinar cells (Fig. 1B and C).
To more accurately assess the effect of deleting β-catenin, we
developed a strategy of absolute volume quantiﬁcation, in which
evenly-spaced sections were collected across a series of slides, to
capture the entire pancreas (see Materials and methods). Integrat-
ing the area occupied by immunostaining for individual markers
allowed us to estimate the absolute volume of pancreas occupied
by speciﬁc cell types. Staining for the pan-epithelial marker
E-cadherin at E17.5 revealed a 10-fold reduction in overall pan-
creas size in PBKO compared to controls (Fig. 1D–F). The drastic
reduction in size is mostly due to the loss of exocrine acinar cells
as shown previously (Murtaugh et al., 2005; Wells et al., 2007),
together with a decrease in duct cells (Fig. 1J). Casual observation
suggested a possible increase in β-cell numbers in PBKO, as β-cells
occupied more of the remnant epithelium than in control pan-
creata. However, quantiﬁcation revealed a 2-fold reduction in
β-cell volume following β-catenin deletion, not documented in
any previous study (Fig. 1G–I). The volume of other endocrine cell
types, including α-cells and δ-cells, exhibited a similar reduction,
representing a deﬁcit in overall islet cell mass (Fig. 1J). Impor-
tantly, the size of β-cells was indistinguishable between wild-type
and mutant (Fig. S1A–C), conﬁrming that the decrease in β-cell
volume reﬂected a decrease in β-cell numbers.
Because Pdx1-Creearly deletes β-catenin in early pancreatic
progenitor cells, analysis of late fetal PBKO pancreata cannot
distinguish between defects that arise early, in time or lineage
progression, from those arising late. We were particularly inter-
ested in establishing if the decreased β-cell mass in PBKO reﬂected
a requirement for β-catenin in insulinþ cells themselves and/or in
Ngn3þ endocrine precursors. We used an Ngn3-Cre BAC trans-
genic mouse line (Schonhoff et al., 2004) to delete Ctnnb1
speciﬁcally in Ngn3þ precursors and their progeny, avoiding any
potential effect in Pdx1þ MPCs. In contrast to Pdx1-Creearly-
mediated deletion, we found no change to β-cell mass following
deletion with Ngn3-Cre (Fig. 1K–M). These data suggest that β-
catenin acts at a stage prior to endocrine speciﬁcation to establish
both normal pancreas size and normal β-cell mass.
To determine the speciﬁc period in which β-catenin was
required during development, we compare wild-type and mutant
pancreas size at several developmental time points. Although
pancreas size was not signiﬁcantly affected at E11.5, β-catenin
deﬁcient pancreata were signiﬁcantly smaller than control begin-
ning at E12.5, the discrepancy increasing with time (Fig. 2).
Interestingly, the timing of the PBKO pancreas hypoplasia pheno-
type corresponds approximately to the classically-described “sec-
ondary transition” (Pan and Wright, 2011; Pictet and Rutter, 1972),
deﬁned by an exponential increase in the numbers of differentiated
Fig. 1. β-Catenin is required for pancreas and β-cell mass prior to endocrine speciﬁcation. Pdx1-Cre (PBKO) or Ngn3-Cre (IsBKO) β-catenin knockout pancreata were analyzed
and compared to controls at E17.5. (A) Breeding scheme to generate control and KO genotypes. (B and C) H&E staining of E17.5 pancreata reveals a dramatic loss of acinar
tissue (pink) in PBKO compared to control. (D–F) Pancreata (red-dashed outline) stained with the pan-epithelial marker E-cadherin to determine total pancreas size exhibit a
10-fold reduction in PBKOs compared to controls. (G–I) Although insulinþ β-cells occupy a greater proportion of PBKO pancreatic epithelia (adjacent sections to D and E),
quantiﬁcation reveals a 2-fold reduction in absolute β-cell volume. (J) Quantiﬁcation of ducts (DBA-lectinþ), α-cells (glucagonþ), and δ-cells (somatostatinþ), normalized to
controls at E17.5, demonstrates that PBKOs have reduced exocrine and endocrine numbers. (K and M) IsBKO (Ngn3-Cre) and control pancreata show no difference in β-cell
volume at E17.5. The number of embryos analyzed per genotype is indicated at the bottom of each bar.
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endocrine and exocrine cells. As our quantitative analysis identiﬁed
E12.5 as the ﬁrst stage at which phenotypic changes could be
observed in PBKO, we focused our studies on this period to
characterize and quantify changes to the MPC population.
Early loss of distal MPCs in β-catenin-deﬁcient pancreata
Lineage tracing studies reveal that all mature pancreatic cell
types arise from MPCs (Zhou et al., 2007). Following speciﬁcation
and prior to the secondary transition, the pancreatic epithelium
segregates into a MPC-containing distal tip domain and a proximal
trunk domain that comprises duct and endocrine precursors (Pan
and Wright, 2011; Zhou et al., 2007). To characterize any changes
to the distal MPC population, we stained and quantiﬁed potential
MPCs at E12.5, labeled independently with three markers, Ptf1a,
carboxypeptidase 1 (Cpa1) and c-Myc (Zhou et al., 2007). We
found MPC numbers to be dramatically reduced in PBKO, regard-
less of the marker used (Fig. 3A–C, D–F, and G–I). This reduction is
not simply explained by the overall decrease in PBKO epithelial
volume, as the proportion of Ptf1aþ cells within the pancreas was
also dramatically reduced (Fig. S2A). The remaining Ptf1aþ cells
found in PBKO pancreata likely represent “escaper” cells that fail to
delete β-catenin, and later provide the only source of residual
acinar cells in these embryos (Murtaugh et al., 2005). Overall, the
morphology of the PBKO epithelium resembled a proximal trunk
domain devoid of branching tips.
In addition to staining for distal tip MPCs, we looked for any
potential defects within the proximal and pre-endocrine popula-
tions by staining for Sox9 or Ngn3, respectively. At E12.5, Sox9 is
still expressed in both the distal and proximal domain, and we
observed no change in the Sox9 expression pattern (Fig. S3).
However, in contrast to the loss of distal MPCs, we found an
unexpected increase of Ngn3þ cells, both in absolute number and
as a proportion of the trunk epithelium (Figs. 3J–L and S2B).
Furthermore, some Ngn3þ cells remained in the distal domain
one day later, at E13.5 (data not shown). Consistent with the bias
of early Ngn3þ cells toward the α-cell lineage (Johansson et al.,
2007), we found a modest increase in glucagonþ cells in PBKOs at
this time, suggesting that extra Ngn3þ cells present at E12.5 in
PBKOs had differentiated (Fig. S4). Given that acinar cells arise
from distal tip MPCs persisting at the secondary transition (Zhou
et al., 2007), our data suggest that the acinar deﬁcit of PBKO mice
reﬂects an earlier defect in maintenance of distal tip identity, such
that β-catenin-deﬁcient distal MPCs take on proximal “trunk” cell
characteristics.
Pancreatic patterning is established but not maintained in PBKO
Given that β-catenin-deﬁcient pancreata contained fewer distal
MPCs at E12.5 than controls, we sought to determine whether
β-catenin was required for establishing or maintaining MPC
identity and distal patterning. We identiﬁed MPCs at E11.5, a time
point prior to any noticeable decrease in total epithelial size, based
on their expression of Ptf1a or c-Myc (Zhou et al., 2007), and found
no signiﬁcant difference in the number of Ptf1aþ cells between
controls and PBKOs (Fig. 4A–C). The number of c-Mycþ cells,
however, was already reduced in E11.5 PBKOs compared to
controls (Fig. 4D–F), similar to our ﬁndings at E12.5. Importantly,
c-Myc is a β-catenin target gene (He et al., 1998) and known to
promote pancreatic epithelial proliferation (Bonal et al., 2009;
Nakhai et al., 2008), suggesting that its loss of expression reﬂected
loss of β-catenin signaling activity.
Interestingly, the total number of Ptf1aþ cells present in E11.5
PBKOs was greater than the number at E12.5 (Fig. 4C), suggesting
that the deﬁcit observed at the later stage may reﬂect more than a
simple failure to expand. Conﬁrming previous results (Murtaugh
et al., 2005), we found no detectable increase in cell death in PBKO
pancreata at these stages (data not shown). We therefore interpret
our results as indicating normal MPC speciﬁcation at E11.5,
followed by a progressive shift from distal to proximal fate of
these cells in the absence of β-catenin function.
To test the hypothesis that β-catenin acts post-speciﬁcation to
support MPC maintenance and acinar development, we used the
tamoxifen-inducible Pdx1-CreERT deletor (Gu et al., 2002) to
achieve temporal control of Ctnnb1 recombination. We also bred
in the Cre-dependent R26REYFP reporter (Srinivas et al., 2001),
allowing for lineage tracing of EYFPþ/β-catenin-deﬁcient cells.
These mutant embryos are referred to as mPBKO, for mosaic
pancreas-speciﬁc β-catenin knockout. We ﬁrst administered
tamoxifen to pregnant dams at E10.5 and harvested pancreata at
E17.5, analyzing EYFP distribution to determine the fate of
manipulated cells. Our previous study using constitutive Pdx1-
Cre indicated that β-catenin-deﬁcient cells are excluded from the
acinar lineage while remaining competent for β-cell differentia-
tion (Murtaugh et al., 2005). Consistent with this, we found a
dramatic reduction in the acinar contribution of EYFPþ cells in
mPBKO pancreata following E10.5 TM treatment, while β-cell
Fig. 2. Progressive growth defect in β-catenin mutant pancreata. PBKO or control pancreata from E11.5, E12.5 and E17.5 were stained with the pan-epithelial marker
E-cadherin to determine overall pancreas size (dashed outline). (A and B) At E11.5, pancreas size is similar between PBKOs and controls. (C and D) At E12.5, PBKO pancreata
are smaller and contain fewer distal branches than controls. (E and F) Staining for the pan-epithelial marker E-cadherin at E17.5 indicates a dramatic deﬁciency of epithelial
tissue in PBKOs compared to controls. Control and mutant images photographed at identical magniﬁcations, as indicated. (G) Volume quantiﬁcation of E-cadherin-stained
surface area (graphed on the log axis) reveals a size deﬁcit in PBKO pancreata beginning at E12.5, increasing through E17.5.
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labeling remained comparable to controls (Fig. S5). Our mosaic
deletion/labeling approach thus provides independent evidence
that β-catenin is required in the acinar lineage, and indicates that
this requirement applies during stages of MPC expansion.
To examine more closely the fate of β-catenin deﬁcient MPCs,
we administered tamoxifen at either E8.5 (during/prior to MPC
speciﬁcation) or E10.5 (following speciﬁcation), and harvested
embryos 3 days later at either E11.5 or E13.5, respectively. In the
E8.5–E11.5 pulse-chase paradigm, we found that Cpa1þ MPCs
exhibited a similar EYFP labeling index in control and mPBKO
(Fig. 5A–C), consistent with a lack of requirement for β-catenin in
the initial generation of MPCs. Staining for β-catenin protein
conﬁrmed that labeled cells in mPBKO pancreata were β-
catenin-deﬁcient (Fig. 5B). In the E10.5–E13.5 paradigm, however,
we found that Cpa1þ cells were labeled much less frequently in
mPBKOs than in controls, and EYFPþ cells were generally
excluded from distal tips and conﬁned to proximal trunk regions
(Fig. 5D–F). Moreover, we found that the majority of EYFPþ
Cpa1þ cells in E10.5–E13.5 mPBKOs were “escapers” that had
not successfully deleted Ctnnb1, as indicated by β-catenin staining
(Fig. 5E). Together with the results of our PBKO studies, above,
these lineage tracing experiments suggest that β-catenin is
required for MPC maintenance and proximal–distal patterning,
and acts during MPC expansion rather than speciﬁcation.
β-Catenin regulates proliferation independent of proximal–distal
patterning
Intuitively, if MPC numbers are determined by integrating their
self-renewal with differentiation to a bipotent proximal fate (Zhou
et al., 2007), then the progressive MPC depletion we observe in
PBKO between E11.5 and E12.5 (Fig. 4C) could reﬂect a growth
arrest of these cells. Indeed, Wnt/β-catenin signaling is well
known to regulate proliferation in many tissues, including mature
acinar cells (Keefe et al., 2012; Polakis, 2012; Schuijers and Clevers,
2012), and decreased proliferation has been documented in
β-catenin mutant pancreata, albeit at isolated time points and
without reference to speciﬁc cell types affected (Dessimoz et al.,
2005; Murtaugh et al., 2005; Wells et al., 2007).
Fig. 3. Proximalization of β-catenin deﬁcient pancreata during MPC expansion. E12.5 mutant and control pancreata were stained for Ptf1a, Cpa1 and c-Myc to label distal
MPCs, and Ngn3 to label endocrine precursors (epithelia are outlined in red). (A–C) Control Ptf1a staining identiﬁes MPCs localized to the distal tips of the expanding
epithelium. PBKO pancreata contained fewer distal tips and fewer Ptf1aþ cells than age-matched controls, conﬁrmed by quantiﬁcation. (D–F) Similar to Ptf1a, the distal MPC
marker Cpa1 exhibits a dramatic decrease in PBKOs compared to controls. (G–I) Cells expressing the Wnt target gene c-Myc are identiﬁed in distal tips of control but not
PBKO pancreata. (J–L) Staining for the endocrine precursor marker Ngn3shows an absolute increase in Ngn3þ cells in PBKOs, with some Ngn3þ cells localizing abnormally
to distal tips rather than being conﬁned to the proximal trunk domain. Quantiﬁcation of Ptf1a, c-Myc and Ngn3 is represented as the total number of cells calculated per
pancreas.
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To determine the spatiotemporal requirements for β-catenin in
MPC proliferation, we injected pregnant mice with BrdU to label
proliferating cells one hour prior to harvest at E11.5, E12.5 and
E13.5, and analyzed BrdU labeling of Cpa1þ distal MPCs. Surpris-
ingly, we found similar levels of proliferation between controls
and PBKOs at E11.5 (Fig. 6A–F). Beginning at E12.5 and continuing
through E13.5, however, PBKO cells incorporated BrdU less fre-
quently than age-matched controls (Fig. 6G–L and M–R). We
calculated the percentage of BrdUþ cells among all pancreatic
epithelial cells, marked in this experiment by activation of
R26REYFP, as well as in Cpa1þ cells speciﬁcally, and found no
signiﬁcant difference in proliferation in either population at E11.5.
Cpa1þ cell proliferation remained constant in controls through all
periods, whereas overall proliferation begins to decline at E13.5. In
PBKOs, both overall and Cpa1þ cell proliferation fell dramatically
at E12.5 and remained reduced at E13.5 (Fig. 6S and T). With little
or no proliferation defect in mutant MPCs at E11.5, their rapid
disappearance over the next 24 h is most readily explained by a
Fig. 4. Proximal–distal patterning is established in the absence of β-catenin. E11.5 pancreata were stained with Ptf1a and c-Myc to label and quantify distal MPCs. Total cell
number indicates the number of labeled cells calculated per pancreas. (A and B) Ptf1a staining is similar between control and PBKO at this stage, with Ptf1aþ cells localized
to the distal periphery. (C) Ptf1aþ cells at E11.5 show a non-signiﬁcant difference between PBKO and control. The total number of Ptf1aþ cells (reproduced from Fig. 3C)
increased in controls from E11.5 to E12.5, and decreased in PBKOs. (D and E) Staining for c-Myc reveals a decrease in the number of c-Mycþ cells in PBKOs compared to
controls. (F) C-Mycþ cells are markedly decreased in E11.5 PBKO pancreata.
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key requirement for β-catenin in distalization of the epithelium.
Our results suggest that the loss of MPCs, through altered
patterning leading to premature differentiation as well as through
reduced proliferation, ultimately diminishes inﬂux into the pool of
precursors that generates β-cells later in development (Fig. 7H).
Notch signaling is required for proximalization induced by loss
of β-catenin
Elimination of β-catenin and elimination of Notch signaling
have opposite patterning consequences in the developing pan-
creas: whereas loss of β-catenin produces a shift toward proximal/
trunk patterning, the inhibition of Notch promotes distal/tip cell
development (Afelik et al., 2012; Magenheim et al., 2011). More-
over, ectopic activation of Notch prevents acinar cell differentia-
tion, similar to β-catenin loss-of-function (Esni et al., 2004; Hald
et al., 2003; Murtaugh et al., 2003). Notch and Wnt/β-catenin have
been found to have antagonistic effects in other experimental
systems as well, although this appears to be context-speciﬁc
(Acosta et al., 2011; Hayward et al., 2005; Kwon et al., 2011). To
determine the relationship between these pathways in the pan-
creas, we cultured E11.5 PBKO pancreata in the absence or
presence of the gamma-secretase inhibitor DBZ, which inhibits
ligand-induced Notch receptor activation (Magenheim et al., 2011;
Milano et al., 2004). After 3 days of culture, untreated PBKO
explants developed few Cpa1þ tip/pro-acinar cells, most of which
represented β-cateninþ “escaper” cells (Fig. 7A–C). DBZ-treated
PBKO explants, however, developed large numbers of Cpa1þ cells
within β-catenin deﬁcient areas (Fig. 7D–F). Notably, the number
of Cpa1þ escaper cells was not increased by DBZ, indicating that
Notch inhibition did not induce generalize hyperplasia of tip/pro-
acinar cells (Fig. 7G). These results provide insight into the
mechanism by which β-catenin normally promotes distal fate,
namely by inhibiting the ability of Notch to drive tip-to-trunk
conversion (Fig. 7H).
Discussion
We previously found that the multifunctional protein β-catenin
was required for pancreatic acinar development but dispensable
for endocrine differentiation and function (Murtaugh et al., 2005).
We have revisited the pancreas-speciﬁc β-catenin knockout model
to reveal a requirement for β-catenin in generating normal islet
cell numbers and, through the use of lineage-restricted Cre deletor
lines, we demonstrate that this requirement is imposed prior to
endocrine speciﬁcation. β-catenin has two distinct roles in the
early pancreas: it promotes distal patterning of the epithelium by
inhibiting Notch, and it is required for maximal proliferation
throughout the developing organ (Fig. 7). Our ﬁndings provide
Fig. 5. β-Catenin is required to maintain but not establish distal tip cell identity. Control (Ctnnb1lox/þ; R26REYFP/þ; and Pdx1-CreERT/þ) and mosaic pancreas-speciﬁc
β-catenin knockout (mPBKO: Ctnnb1Δ/lox; R26REYFP/þ; and Pdx1-CreERT/þ) embryos received tamoxifen in utero at either E8.5 or E10.5 and were analyzed 3 days later (E11.5
and E13.5, respectively) by immunoﬂuorescence. (A) Cpa1þ distal cells (red) from control pancreata given tamoxifen at E8.5 and harvested at E11.5 co-express EYFP (green)
as indicated by yellow arrowheads. Monochrome panels depict single color channels for Cpa1 and EYFP, from area highlighted in dashed box, together with β-catenin protein
(not included in the merge, but taken from the same ﬁeld), and conﬁrm that β-catenin is expressed by EYFPþ Cpa1þ cells in control (closed arrowheads). (B) Cpa1þ cells
(red) frommPBKO littermates co-express EYFP (green). Single color channels indicate that most EYFP-labeled Cpa1þ cells are β-catenin-deﬁcient (open arrowheads). (C) The
EYFP labeling indices of Cpa1þ cells remain similar between controls and mPBKO. (D) Cpa1þ distal tip cells from controls given tamoxifen at E10.5 and harvested at E13.5
co-express EYFP and β-catenin. (E) In mPBKO littermates, EYFPþ and β-catenin-deﬁcient cells are generally excluded from distal Cpa1þ tips. Remaining Cpa1þ EYFPþ cells
retain β-catenin expression, indicating a selection for MPCs that have not deleted β-catenin (closed arrowheads). Open arrowheads indicate unlabeled, β-cateninþ Cpa1þ
cells that comprise a large majority of the Cpa1þ population. (F) After an E10.5 TM pulse, control Cpa1þ cells retain a higher EYFP labeling index than mPBKO.
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new insight into the molecular mechanisms of pancreas morpho-
genesis and differentiation, as well as reconcile previous studies of
β-catenin knockout pancreata.
Whereas several prior studies found no change in islet cell
number or function following deletion of β-catenin (Murtaugh et
al., 2005; Wells et al., 2007), a separate study suggested that islet
cell numbers declined following β-catenin deletion, reﬂecting
islet-restricted Wnt-β-catenin transcriptional activity (Dessimoz
et al., 2005). To avoid problems of overestimating β-cell mass due
to changes in the overall organ structure (Kopp et al., 2011), we
used a quantitative approach that captures the absolute rather
than relative volume occupied by speciﬁc pancreatic cell types,
and discovered a more drastic loss of β-cells in mutant pancreata
than previously reported. However, and consistent with our recent
ﬁnding that postnatal β-cell proliferation is β-catenin-independent
(Keefe et al., 2012), we ﬁnd that islet precursor-restricted deletion
of β-catenin does not recapitulate the loss of islet mass caused by
deletion in MPCs. Therefore, we conclude that β-catenin acts prior
to endocrine speciﬁcation, maintaining and expanding MPC num-
bers sufﬁcient to establish normal islet mass (Stanger et al., 2007).
In the absence of β-catenin, MPCs are proximalized and prematurely
generate early endocrine precursors, biased toward glucagonþ α-cells
(Johansson et al., 2007), and are not subsequently available in
sufﬁcient numbers to generate the full complement of β-cells. Overall
decreased islet cell genesis in the absence of β-catenin may also reﬂect
antagonism between this protein and Notch, uncovered here, as
hyperactive Notch is known to inhibit endocrine development
(Hald et al., 2003; Murtaugh et al., 2003). Further studies will be
required to parse the roles of β-catenin and Notch in MPCs and
trunk cells.
How does β-catenin regulate MPC numbers? Importantly, we ﬁnd
that the initial speciﬁcation, patterning and proliferation of MPCs are
normal in PBKO pancreata, through E11.5, but notably aberrant as
soon as 24 h later. In particular, the progressive disappearance of
MPCs, and the increased number of Ngn3þ cells, indicates a defect in
maintaining the early proximal–distal pattern of the organ, indepen-
dent of effects on proliferation. Proliferation is impaired in PBKO
pancreata, a defect that may reﬂect, in part, loss of expression of the
Wnt target gene cMyc (Bonal et al., 2009; Nakhai et al., 2008). Direct
inhibition of Wnt signaling in the pancreas, through expression of a
dominant-negative Fz8 mutant, impairs proliferation without any
obvious effect on patterning or differentiation (Papadopoulou and
Edlund, 2005). We are therefore tempted to speculate that the
proliferation-speciﬁc effects of β-catenin reﬂect activity of the cano-
nical Wnt signaling pathway, while effects on patterning may reﬂect
Wnt-independent β-catenin functions, possibly including cross-talk
with Notch. In future studies, we hope to address this issue with new
genetic tools that we and others have developed to selectively disrupt
Wnt/β-catenin signaling (Barrott et al., 2011; Valenta et al., 2011). If
β-catenin has distinct modes of action, it may be possible to
selectively proximalize early epithelial cells, promoting islet precursor
development, while maintaining normal or even increased prolifera-
tion of progenitor cells. Such an intervention could be critical to
efﬁciently generate β-cells from human ES or iPS cells.
Fig. 6. β-Catenin is required after E11.5 for epithelial proliferation. Control (Ctnnb1lox/þ; R26REYFP/þ; and Pdx1-Cre/þ) and PBKO (Ctnnb1Δ/lox; R26REYFP/þ; and Pdx1-Cre/þ)
littermates received BrdU in utero one hour prior to sacriﬁce at E11.5, E12.5 or E13.5, and proliferation index was assessed via BrdU immunostaining (red). All pancreatic
epithelial cells are EYFP-labeled (light green) due to Pdx1-Cre recombination of R26REYFP, while Cpa1þ cells appear as bright green. White boxes indicate areas with
expanded views seen in the adjacent panels. (A–C) E11.5 controls contain both BrdUþ Cpa1þ distal and BrdUþ Cpa1 -proximal cells. (D–F) Distal cells from PBKO at E11.5
are BrdU labeled at levels comparable to controls (yellow arrowheads). (G–I) At E12.5, comparable BrdU labeling is seen between Cpa1þ and Cpa1- of controls. (J–L) BrdU
labeling is reduced in E12.5 PBKOs, regardless of Cpa1 expression status. (M–O) Distal cells are commonly BrdU labeled in E13.5 controls. (P–R) BrdUþ cells are dramatically
reduced throughout the PBKO epithelium at E13. (S) BrdU labeling indices for EYFPþ cells at E11.5, E12.5 and E13.5 reveal that maximal epithelial proliferation requires β-
catenin function only after E11.5. (T) Proliferation indices calculated for the Cpa1þ population in PBKOs and controls.
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The fact that β-catenin is essentially dispensable before E12.5
may explain the previous paradoxical ﬁnding that early activation
of β-catenin actually causes pancreas agenesis (Heiser et al., 2006).
This result was obtained with Pdx1-Creearly, which induces recom-
bination prior to MPC speciﬁcation; activation of β-catenin follow-
ing the secondary transition, with Pdx1-Crelate, results in exocrine
pancreas hyperplasia. We suggest that the signaling function of
β-catenin is normally inactive prior to MPC speciﬁcation, and that
its hyperactivation at early stages may respecify the organ to an
alternative developmental fate (Heller et al., 2002; McLin et al.,
2007).
The basis for the transition to β-catenin dependence, for both
patterning and proliferation, remains unknown. We note, how-
ever, that it appears to occur simultaneously with several other
regulatory transitions, including resolution of epithelial branching
(Villasenor et al., 2010), establishment of mutually repressive
Nkx6.1 and Ptf1a expression domains (Schaffer et al., 2010), and
upregulation of the Ptf1a autoregulatory enhancer (Masui et al.,
2008). Our results would be consistent with any or all of these
transitions requiring β-catenin function, and we are interested to
determine the mechanism or mechanisms by which β-catenin
orchestrates these and other early processes to allow subsequent
elaboration of organ growth and differentiation.
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